Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // July 7th, 2010 // 7:02 am
Another hot day here on the Pharmalot corporate campus, where we are keeping the water bottles handy. We hope you are doing the same. After all, a flash of hot news does not require you to get overheated. Meanwhile, there is plenty of work to keep us busy. So please join us as we survey the headlines and dig in for another round of meetings and deadlines. Stay cool, everyone…
Migraine Drug From Glaxo And XenoPort Fails Test (Associated Press)
Aspen Lowers Its Offer For Sigma Pharma (Bloomberg News)
India Expands Role As Drugmaker (New York Times)
Roche Submits Breast Cancer Drug To FDA (Reuters)
University Presses Invention Lawsuit Against Pfizer (Salt Lake City Tribune)
Drugmakers To Boost Efforts Against Doping (Financial Times)
Germany Seeks Cuts From Pharma & Insurers (PharmaTimes)
Pfizer Calls Review On Advil Ad Account (Ad Age)
Canada Should Be China’s Global Vaccine Partner (InPharmaTechnologist)
Pfizer Gets EU Approval For Kids Lipitor (Associated Press)
Health Insurers May Offer Contraceptives At No Cost (Washington Post)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Advertising, Advil, Aspen Pharmaceuticals, Breast Cancer, Brigham Young University, Canada, Celebrex, China, Contraceptives, Doping, Germany, India, Lipitor, Pfizer, Roche, Sigma Pharmaceuticals, Vaccines